Skip to main content
“Hey PRESTO!” – Early identification of psoriatic arthritis

The past decade has seen the management of psoriatic

Dr. John Cush RheumNow

2 weeks 6 days ago
“Hey PRESTO!” – Early identification of psoriatic arthritis The past decade has seen the management of psoriatic arthritis (PsA) transform, with our rich therapeutic armamentarium truly revolutionising patient outcomes.https://t.co/FJNX3mGCoy https://t.co/Whd8QKwmkU
Effect of voclosporin in class V lupus nephritis

Dr. Yusof ( @Yuz6Yusof) discusses abstract 0355 presented at #ACR22.

Dr. John Cush RheumNow

3 weeks ago
Effect of voclosporin in class V lupus nephritis Dr. Yusof ( @Yuz6Yusof) discusses abstract 0355 presented at #ACR22. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study https://t.co/v716QGx73g https://t.co/ANTOEDAAHt
The CONSUL Trial: Ankylosing Spondylitis

Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract 0546 presented at #ACR22.

Dr. John Cush RheumNow

3 weeks ago
The CONSUL Trial: Ankylosing Spondylitis Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract 0546 presented at #ACR22. https://t.co/DXTn3XfEzC https://t.co/pbORtBsRm2
JAK vs TNF inhibitor Infections in RA

Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. A

Dr. John Cush RheumNow

3 weeks ago
JAK vs TNF inhibitor Infections in RA Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis https://t.co/GsOsWtuT7v https://t.co/GloKEcB75L
Does BASDAI work for women?

In Abstract 0406 S. Maguire et al sought to understand if BASDAI and BASFI captured diseas

Dr. John Cush RheumNow

3 weeks ago
Does BASDAI work for women? In Abstract 0406 S. Maguire et al sought to understand if BASDAI and BASFI captured disease activity and quality of life in female axSpA patients. Read more from Dr. Rachel Tate ( @uptoTate ) #ACR22 https://t.co/yWzdRMPgpp https://t.co/YrMsAYbAWN
Sleep asleep
For people living with psoriatic arthritis (PsA), the comfort of a good night's sleep may feel out of reach for many.
gout.MTP_.jpg
In abstract 0001 presented at ACR22 Convergence, researchers presented 12-month data from a randomized double-blind placebo-controlled trial of pegloticase with or without MTX.
lupus SLE
Inhibition of B-cell Activating Factor (BAFF) has revolutionised the treatment of patients with systemic lupus erythematosus. However, outcomes of therapies within the same class (i.e. BAFF-inhibitor) when evaluated in randomised controlled trials have been inconsistent.
ACR Best Abstracts - Day 3

The last day was jammed with important reports and research including the late breaking ab

Dr. John Cush RheumNow

3 weeks ago
ACR Best Abstracts - Day 3 The last day was jammed with important reports and research including the late breaking abstracts. These were some of our favorites. #ACR22 https://t.co/vUrxBTF3Wj https://t.co/QKpTjyFfxt
RT @ericdeinmd: #ACR22 final plenary session
10 week study outcomes of Philly vs Placebo to be reported
#rheumpix @Rheum

Eric Dein ericdeinmd

3 weeks ago
#ACR22 final plenary session 10 week study outcomes of Philly vs Placebo to be reported #rheumpix @RheumNow https://t.co/BradH2Ty70
×